Product References — pooled human complement plasma
Myelin Oligodendrocyte Glycoprotein-IgG Contributes to Oligodendrocytopathy in the Presence of Complement, Distinctfrom Astrocytopathy Induced by AQP4-IgG
Posted by Corey Marcath on
Pooled Human Complement Serum from Innovative Research was used in the following study: Myelin Oligodendrocyte Glycoprotein-IgG Contributes to Oligodendrocytopathy in the Presence of Complement, Distinctfrom Astrocytopathy Induced by AQP4-IgG Ling Fang, Xinmei Kang, Zhen Wang, Shisi Wang, Jingqi Wang, Yifan Zhou, Chen Chen, Xiaobo Sun, Yaping Yan, Allan G. KermodeLisheng Peng, Wei Qiu Neuroscience Bulletin 18 January 2019 “...Immunoglobulin G against myelin oligodendrocyte glycoprotein (MOG-IgG) is detectable in neuromyelitis optica spectrum disorder (NMOSD) without aquaporin4 IgG (AQP4-IgG), but its pathogenicity remains unclear. In this study, we explored the pathogenic mechanisms of MOG-IgG in vitro and in vivo and compared...
Posted by Leanne Kodsmann on
Human Complement from Innovative Research was used in the following study: Complement-dependent bystander injury to neurons in AQP4-IgG seropositive neuromyelitis optica Tianjiao Duan, Alex J. Smith and Alan S. Verkman Journal of Neuroinflammation, October 2018 "... Specified concentrations of AQP4-IgG (or control human IgG, Thermo Fisher Scientific, Rockford, IL) and human complement (Innovative Research, Novi, MI) were added in Hank’s buffer, and cells were incubated at 37 °C for specified times. In some experiments, cells were exposed to serum of an AQP4-IgG seropositive NMO patient who met the revised diagnostic criteria for clinical disease. A fixable dead-cell stain (amine-reactive dye,...
- Tags: Human Deficient Plasma, human plasma, Human Serum, Journal: Journal of Neuroinflammation, pooled human complement plasma, Pooled Human Complement Serum, single donor human complement serum